PGI16 COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER BIOLOGIC FAILURE OR INTOLERANCE IN SPAIN
Abstract
Authors
L. Menchén F. de Andrés-Nogales S. García A. Sánchez-Guerrero B. Menchen A. Cábez S. Gómez A. López M.Á. Casado C. Peral C. Taxonera